Dostarlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms:

Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1  programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.

Dostarlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

Batch: A283501 Purity: 99% Protein concentration: 4.22mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1  programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.

Product Details

CAS No. 2022215-59-2
Molecular Weight 144.18
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dostarlimab (Anti-PDCD1 / PD-1 / CD279) | Dostarlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Dostarlimab (Anti-PDCD1 / PD-1 / CD279) | Dostarlimab (Anti-PDCD1 / PD-1 / CD279) cost | Dostarlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Dostarlimab (Anti-PDCD1 / PD-1 / CD279) | Dostarlimab (Anti-PDCD1 / PD-1 / CD279) distributor